GL vs RYTM · P/E 10, $10.26B cap vs rev $130.1M
Globe Life Inc (GL) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Globe Life Inc (GL) is a insurance - life company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
GL does not have a complete income-statement cache yet.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
GL currently screens at market cap $10.26B and trailing P/E 10.1. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the GL and RYTM stock pages for the full models.
Not investment advice.